David A. Siegel Precigen, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Precigen, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 83,600 shares of PGEN stock, worth $294,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,600
Previous 81,700
2.33%
Holding current value
$294,272
Previous $121,000
2.48%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PGEN
# of Institutions
167Shares Held
166MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$294 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$57.3 Million1.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$39.7 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$36.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$31.9 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $733M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...